CLINICO-EPIDEMIOLOGICAL PROFILE AND HOSPITAL OUTCOMES OF COVID-19 PATIENTS DURING ALL THREE WAVES, AN EXPERIENCE FROM A RURAL TERTIARY CARE CENTER, EASTERN UTTAR PRADESH, INDIA

Authors

  • SURABHI SHUKLA Department of Microbiology, MVAS Medical College, Basti, UP, India
  • NAVEEN GOYAL Department of Internal Medicine, Rohilkhand Medical College and Hospital, Bareilley, Uttar Pradesh, India https://orcid.org/0009-0007-8868-9189
  • PRIYANKA RAI Department of Pathology, Maharshi Devraha Baba Autonomous State Medical College, Deoria, Uttar Pradesh, India https://orcid.org/0000-0002-1458-9579
  • SWARAJ SHARMA Department of Transfusion Medicine, Maharshi Vashishtha Autonomous State Medical College, Basti, Uttar Pradesh, India https://orcid.org/0009-0004-0514-3059
  • VINOD KUMAR MAURYA Department of Microbiology, Maharshi Vashishtha Autonomous State Medical College, Basti, Uttar Pradesh, India https://orcid.org/0000-0001-9746-8299
  • VIKAS KUMAR GUPTA Department of Biochemistry, MVAS Medical College, Basti, UP, India

DOI:

https://doi.org/10.22159/ijcpr.2024v16i1.4014

Keywords:

Level-2 COVID hospital, Northern India, Rural tertiary care center, Clinical profile

Abstract

Objective: In this study, an attempt has been made to report the clinical profile, exposure characteristics and outcomes of the COVID-19 patients admitted to our rural tertiary care facility.

Methods: It is a single-centric retrospective observational study and includes data from January 2020 to March 2022. The data were retrieved from patient files. We have recorded patient demography, clinical and laboratory parameters and outcome of the patients. Patients were categorized based on disease severity according to WHO guidelines. Appropriate statistical analysis was applied and p value<0.05 was considered as significant.

Results: A total of 2339 patients were included in this study. Total males were 67%, mean age group was 45.43±18.48 y (0 to 101 y), with majority belonging to 46-60 y age group (27.2%). Total comorbid patients were 29.3% with 9.4% accounting for more than one comorbidities. Most common comorbidity noted was diabetes mellitus 15.8% followed by hypertension 13.4%. Total mortality was noted to be 16.2%. Fever was the most common symptom (92%) followed by cough (51%) and myalgia (30%). Disease severity and outcome was significantly correlated with advancing age and the presence of underlying comorbidities.

Conclusion: Rural population had comparable proportion of comorbidities as well as mortality. Common risk factors for severe disease in rural setting were similar to urban setting and old age and more than one comorbidities. Country-wide rural data should be collected for a better understanding of COVID-19 disease in rural and remote population.

Downloads

Download data is not yet available.

References

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. doi: 10.1056/NEJMoa2001017, PMID 31978945.

World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19-11 Mar 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-oncovid-19-11-march-2020. [Last accessed on 01 Jun 2020].

World Health Organization. Coronavirus disease 2019(COVID-19) situation Report-94. Geneva: WHO; 2019. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. [Last accessed on 18 Apr 2022].

Andrews MA, Areekal B, Rajesh KR, Krishnan J, Suryakala R, Krishnan B. First confirmed case of COVID-19 infection in India: a case report. Indian J Med Res. 2020;151(5):490-2. doi: 10.4103/ijmr.IJMR_2131_20, PMID 32611918.

Directorate General of Health Services (EMR Division), Ministry of Health and Family Welfare, Government of India. Guidance document on appropriate management of suspect/confirmed cases of COVID-19. Available from: https://www.mohfw.gov.in/pdf/FinalGuidanceonMangaementofCovidcasesversion2.pdf. [Last accessed on 13 Jul 2020]

World Health Organization. Clinical management of COVID-19. Available from: https://www.who.int/publicationsdetail-redirect/clinical-management-of-covid-19. [Last accessed on 09 Jun 2020]

Kumar G, Mukherjee A, Sharma RK, Menon GR, Sahu D, Wig N. Clinical profile of hospitalized COVID-19 patients in first & second wave of the pandemic: insights from an Indian registry-based observational study. Indian J Med Res. 2021;153(5&6):619-28. doi: 10.4103/ijmr.ijmr_1628_21, PMID 34259194.

Reddy DH, Atam V, Rai P, Khan F, Pandey S, Malhotra HS. COVID-19 cases and their outcome among patients with uncommon co-existing illnesses: a lesson from Northern India. Clin Epidemiol Glob Health. 2022 Apr 12;15:101044. doi: 10.1016/j.cegh.2022.101044.

Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21(1):855. doi: 10.1186/s12879-021-06536-3, PMID 34418980.

Sarkar S, Khanna P, Singh AK. Impact of COVID‐19 in patients with concurrent co‐infections: a systematic review and meta-analyses. J Med Virol. 2021 Apr;93(4):2385-95. doi: 10.1002/jmv.26740, PMID 33331656.

Dubey DB, Mishra S, Reddy HD, Rizvi A, Ali W. Hematological and serum biochemistry parameters as a prognostic indicator of severally ill versus mild COVID-19 patients: a study from a tertiary hospital in North India. Clin Epidemiol Glob Health. 2021 Oct-Dec;12:100806. doi: 10.1016/j.cegh.2021.100806, PMID 34179566, PMCID PMC8214724.

Reddy H, Gupta S, Khan F, Pandey VA, Verma S, Sawlani KK. An initial profile and virological response of SARS-CoV-2 Infected Patients Admitted to Infectious Diseases Hospital of Northern India. Cohesive J Microbiol Infect Dis. 2020;4(4):000592. doi: 10.31031/CJMI.2020.04.000592.

Kar SK, Ransing R, Arafat SMY, Menon V. Second wave of COVID-19 pandemic in India: barriers to effective governmental response. E Clinicalmedicine. 2021 Jun;36:100915. doi: 10.1016/j.eclinm.2021.100915, PMID 34095794, PMCID PMC8164526.

Garg S, Basu S, Rustagi R, Borle A. Primary health care facility preparedness for outpatient service provision during the COVID-19 pandemic in India: cross-sectional study. JMIR Public Health Surveill. 2020 Jun 1;6(2):e19927. doi: 10.2196/19927, PMID 32452819, PMCID PMC7265797.

Thakur K, Sagayaraj A, Prasad KC, Gupta A. Olfactory dysfunction in COVID-19 patients: findings from a tertiary rural centre. Indian J Otolaryngol Head Neck Surg. 2022;74Suppl 2:2840-6. doi: 10.1007/s12070-021-02364-8, PMID 33489853.

Isaac R, Paul B, Finkel M, Moorthy M, Venkateswaran S, Bachmann TT. The burden of COVID-19 infection in a rural Tamil Nadu community. BMC Infect Dis. 2021 Oct 28;21(1):1110. doi: 10.1186/s12879-021-06787-0, PMID 34711193, PMCID PMC8552615.

Teli JG, Reddy S, Kamath V, Jacob MJ, Mohan D, Markanday K. Study of factors associated with COVID-19 mortality in a rural tertiary health care center. APIK J Int Med. 2021;9(4):221-6. doi: 10.4103/ajim.ajim_38_21.

Hasan SN, Srivastva A, Bihari A, Singh PK. Management perspective of COVID-19 patients from L1 till L3 level hospital: an observational study. Natl J Physiol Pharm Pharmacol. 2020;10(11):1002-5. doi: 10.5455/njppp.2020.10.07195202026072020.

Published

15-01-2024

How to Cite

SHUKLA, S., N. GOYAL, P. RAI, S. SHARMA, V. K. MAURYA, and V. K. GUPTA. “CLINICO-EPIDEMIOLOGICAL PROFILE AND HOSPITAL OUTCOMES OF COVID-19 PATIENTS DURING ALL THREE WAVES, AN EXPERIENCE FROM A RURAL TERTIARY CARE CENTER, EASTERN UTTAR PRADESH, INDIA”. International Journal of Current Pharmaceutical Research, vol. 16, no. 1, Jan. 2024, pp. 44-49, doi:10.22159/ijcpr.2024v16i1.4014.

Issue

Section

Original Article(s)